These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 18480347)
1. Identifying patients with familial hypercholesterolaemia in primary care. Humphries SE; Hadfield G Heart; 2008 Jun; 94(6):695-6. PubMed ID: 18480347 [No Abstract] [Full Text] [Related]
2. Mutation screening in patients for familial hypercholesterolaemia (ADH). Taylor A; Patel K; Tsedeke J; Humphries SE; Norbury G Clin Genet; 2010 Jan; 77(1):97-9. PubMed ID: 19843101 [No Abstract] [Full Text] [Related]
3. NICE guidance on familial hypercholesterolaemia: all sugar and spice? Watts GF; Hamilton-Craig I; Sullivan DR Heart Lung Circ; 2009 Jun; 18(3):181-3. PubMed ID: 19119070 [No Abstract] [Full Text] [Related]
4. Familial hypercholesterolaemia: clinical features and management. Pottle A Nurs Stand; 2005 Dec 14-2006 Jan 3; 20(14-16):55-65; quiz 66. PubMed ID: 16372559 [TBL] [Abstract][Full Text] [Related]
5. Defective LDL receptors that are common in a large population. Familial hypercholesterolaemia in South Africa. Gevers W; Casciola LA; Fourie AM; Sanan DA; Coetzee GA; van der Westhuyzen DR Biol Chem Hoppe Seyler; 1987 Oct; 368(10):1233-43. PubMed ID: 3322320 [No Abstract] [Full Text] [Related]
6. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Gray J; Jaiyeola A; Whiting M; Modell M; Wierzbicki AS Heart; 2008 Jun; 94(6):754-8. PubMed ID: 17575326 [TBL] [Abstract][Full Text] [Related]
9. First insights from the EAS familial hypercholesterolaemia collaboration registry: FH is still underdiagnosed and undertreated. Stock J Atherosclerosis; 2019 Nov; 290():138-139. PubMed ID: 31610884 [No Abstract] [Full Text] [Related]
10. Familial hypercholesterolaemia: A global call to arms. Vallejo-Vaz AJ; Kondapally Seshasai SR; Cole D; Hovingh GK; Kastelein JJ; Mata P; Raal FJ; Santos RD; Soran H; Watts GF; Abifadel M; Aguilar-Salinas CA; Akram A; Alnouri F; Alonso R; Al-Rasadi K; Banach M; Bogsrud MP; Bourbon M; Bruckert E; Car J; Corral P; Descamps O; Dieplinger H; Durst R; Freiberger T; Gaspar IM; Genest J; Harada-Shiba M; Jiang L; Kayikcioglu M; Lam CS; Latkovskis G; Laufs U; Liberopoulos E; Nilsson L; Nordestgaard BG; O'Donoghue JM; Sahebkar A; Schunkert H; Shehab A; Stoll M; Su TC; Susekov A; Widén E; Catapano AL; Ray KK Atherosclerosis; 2015 Nov; 243(1):257-9. PubMed ID: 26408930 [No Abstract] [Full Text] [Related]
11. Molecular genetics of familial hypercholesterolaemia in Norway. Leren TP; Tonstad S; Gundersen KE; Bakken KS; Rødningen OK; Sundvold H; Ose L; Berg K J Intern Med; 1997 Mar; 241(3):185-94. PubMed ID: 9104431 [TBL] [Abstract][Full Text] [Related]
12. Genetic screening for familial hypercholesterolaemia in Hong Kong. Tan K; Cheung CL; Yeung CY; Siu D; Leung J; Pang HK Hong Kong Med J; 2018 Jun; 24 Suppl 3(3):7-10. PubMed ID: 29937437 [No Abstract] [Full Text] [Related]
14. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Marks D; Wonderling D; Thorogood M; Lambert H; Humphries SE; Neil HA Health Technol Assess; 2000; 4(29):1-123. PubMed ID: 11109029 [TBL] [Abstract][Full Text] [Related]
15. Improving the global care of familial hypercholesterolaemia: Starting the ball rolling. Ray KK; Watts GF Atherosclerosis; 2018 Oct; 277():230-233. PubMed ID: 30270053 [No Abstract] [Full Text] [Related]
16. Improving identification and management of familial hypercholesterolaemia in primary care: Pre- and post-intervention study. Weng S; Kai J; Tranter J; Leonardi-Bee J; Qureshi N Atherosclerosis; 2018 Jul; 274():54-60. PubMed ID: 29751285 [TBL] [Abstract][Full Text] [Related]
17. Molecular testing for familial hypercholesterolaemia-associated mutations in a UK-based cohort: development of an NGS-based method and comparison with multiplex polymerase chain reaction and oligonucleotide arrays. Reiman A; Pandey S; Lloyd KL; Dyer N; Khan M; Crockard M; Latten MJ; Watson TL; Cree IA; Grammatopoulos DK Ann Clin Biochem; 2016 Nov; 53(6):654-662. PubMed ID: 26748104 [TBL] [Abstract][Full Text] [Related]
18. Current management of children and young people with heterozygous familial hypercholesterolaemia - HEART UK statement of care. Ramaswami U; Humphries SE; Priestley-Barnham L; Green P; Wald DS; Capps N; Anderson M; Dale P; Morris AA Atherosclerosis; 2019 Nov; 290():1-8. PubMed ID: 31536851 [TBL] [Abstract][Full Text] [Related]
19. Another way of screening for familial hypercholesterolaemia. Tyerman PF; Tyerman GV BMJ; 2002 Aug; 325(7359):340. PubMed ID: 12169521 [No Abstract] [Full Text] [Related]
20. Detection of familial hypercholesterolaemia: external validation of the FAMCAT clinical case-finding algorithm to identify patients in primary care. Weng S; Kai J; Akyea R; Qureshi N Lancet Public Health; 2019 May; 4(5):e256-e264. PubMed ID: 31054643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]